Old National Bancorp’s Jazz Pharmaceuticals JAZZ Stock Holding History

Old National Bancorp’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,730	Closed	-$253K	–	691
2023 Q1	$253K	Sell	1,730 -127	-7%	-$18.8K	0.01%	581
2022 Q4	$296K	Hold	1,857	–	–	0.01%	543
2022 Q3	$248K	Buy	+1,857	New	+$282K	0.01%	574
2020 Q1	–	Sell	-1,634	Closed	-$244K	–	527
2019 Q4	$244K	Sell	1,634 -15	-0.9%	-$2.04K	0.01%	479
2019 Q3	$211K	Sell	1,649 -9	-0.5%	-$1.21K	0.01%	519
2019 Q2	$236K	Buy	1,658 +135	+9%	+$18.1K	0.01%	500
2019 Q1	$218K	Buy	+1,523	New	+$199K	0.01%	524
2016 Q3	–	Sell	-1,949	Closed	-$275K	–	631
2016 Q2	$275K	Buy	1,949 +29	+2%	+$4.28K	0.02%	495
2016 Q1	$251K	Sell	1,920 -213	-10%	-$26.5K	0.01%	523
2015 Q4	$300K	Sell	2,133 -730	-25%	-$101K	0.02%	480
2015 Q3	$380K	Buy	2,863 +363	+15%	+$62.5K	0.02%	421
2015 Q2	$440K	Buy	2,500 +1,203	+93%	+$216K	0.02%	389
2015 Q1	$224K	Buy	+1,297	New	+$223K	0.01%	563

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Old National Bancorp's JAZZ Position: Q2 2023 in Review

Old National Bancorp sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2023, closing a stake of 1,730 shares — an estimated $253K sold.

Old National Bancorp first reported a position in JAZZ in Q1 2015 and held it in 13 quarters. The position peaked at $440K in Q2 2015. 471 funds tracked by Wall St. Rank hold JAZZ as of Q2 2023.

Old National Bancorp reported no remaining Jazz Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Old National Bancorp sold 1,730 Jazz Pharmaceuticals shares in Q2 2023, an estimated $253K.
Old National Bancorp first reported a position in Jazz Pharmaceuticals in Q1 2015 and held it in 13 quarters.
Old National Bancorp's Jazz Pharmaceuticals position peaked at $440K in Q2 2015.
471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2023.

Based on Old National Bancorp's 13F filing for Q2 2023, filed 25 Jul 2023.